Logo

sepsis

With Finder Platform, Baebies Works to Expand Options for Neonatal Dx Testing
Premium

The instrument, which is undergoing the FDA clearance process, has the capability to do PCR testing, clinical chemistry, and immunoassays.

T2 Biosystems Advancing Pipeline, Accelerating Instrument Placement Strategy
Premium

The company is working to transition its instruments sold in the US from COVID-19 testing to sepsis testing and increase its installed base.

CARB-X Awards GenomeKey Up to $9.5M to Develop Rapid Diagnostic Test for Sepsis

GenomeKey's technology combines methods to separate bacterial and human DNA, next-generation sequencing, and machine learning.

Baebies Awarded up to $11.6M in CARB-X Funding for Neonatal Sepsis Test

The rapid, point-of-care test is being developed to run on the Durham, North Carolina-based company's Finder digital microfluidics instrument.

Inflammatix Raises $102M in Series D Financing to Continue Development of Immune-Response Tests

The firm said it will use the financing to develop and commercialize its immune response gene-expression diagnostic tests.

Mar 4, 2021

T2 Biosystems Q4 Revenues Jump 152 Percent on Strong Product Sales

Feb 26, 2021

GenMark Diagnostics Seeing Continued Demand for Respiratory Panels, Plans 510(k) Submission
Premium

Jan 27, 2021

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Jan 21, 2021

Molzym, Fraunhofer Developing Rapid Direct-From-Sample Sepsis Diagnostic Platform and Test
Premium

Nov 4, 2020

T2 Biosystems Q3 Revenues Triple, Beat Estimates

Nov 4, 2020

Biocartis to Invest in IVD Partnerships Following Termination of Genomic Health Deal
Premium

Nov 3, 2020

Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform

Oct 15, 2020

Scanogen Developing Direct-From-Blood Infection Test That Could Provide Results in 90 Minutes
Premium

Oct 8, 2020

Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform
Premium

Sep 1, 2020

Immunexpress, Biocartis to Roll Out Sepsis Test in Europe Ahead of Planned US Launch
Premium

Aug 13, 2020

HelixBind Aims to Circumvent Culture With Rapid Technology to Detect Bloodstream Infections
Premium

Aug 11, 2020

T2 Biosystems Q2 Revenues Up 41 Percent, Beat Estimates

Jul 20, 2020

Sepset Biosciences Leveraging COVID-19 Patient Samples in Study to Validate Sepsis Test
Premium

Jul 1, 2020

T2 Biosystems Preliminary Q2 Revenues Up About 40 Percent; Firm Launches COVID-19 Test

Jun 16, 2020

Immunexpress Nabs $599K BARDA Contract to Develop Sepsis Test for Coronavirus Patient Triage

Jun 10, 2020

HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform

May 21, 2020

PrecisionLife Pivots to In Silico Target Validation, COVID-19 Drug Repurposing
Premium

May 14, 2020

DNAe Developing POC Sequencing Platform for Coronavirus, Sepsis
Premium

May 11, 2020

Day Zero Diagnostics Using CARB-X Award to Commercialize Antibiotic-Resistance Testing Platform
Premium

May 8, 2020

Australian Government Awards A$33M in Grants for Genomics Research

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.